Five lessons from investors and operators deploying capital across the continent
The UK remains one of the most attractive healthcare real estate markets in Europe.
That was reflected clearly in audience polling at Carterwood’s MIPIM 2026 session, where the UK ranked highly as an investment destination. The reasons are familiar. It is a relatively mature market, it offers depth, and critically, it has a large private pay segment that gives operators greater pricing flexibility than in many publicly funded systems.
But while the UK continues to attract strong interest, one of the most valuable aspects of this year’s discussion was the opportunity to look beyond it.
With pan-European investors, operators and asset managers on stage, the session offered a useful reminder that the UK does not have all the answers. In fact, some of the most relevant lessons for the UK may now be coming from mainland Europe.
1. The best investors think in value chains, not silos
One of the strongest messages from the panel was that healthcare real estate cannot be understood through a property lens alone.
Across multiple markets, speakers returned to the same point. Real estate performance in healthcare is inseparable from operational performance. That means investors need to understand not just yields and rents, but labour models, regulation, care delivery, staffing pressures and the resilience of the operator itself.
For the UK, this is a timely reminder. There is a tendency in some parts of the market to separate property from operations too neatly. But the most sophisticated capital increasingly sees healthcare real estate as a chain of interdependent factors. The building matters, but so do the operator, the funding model, the workforce and the local demand drivers.
The mainland European perspective reinforces the importance of integrated thinking.
2. Pricing freedom is a major strategic advantage
Spain featured strongly in the session, and one of the reasons is its private pay structure.
As several speakers noted, the ability to set prices more freely gives operators a level of flexibility that is not available in more tightly regulated markets. That flexibility can help offset inflation, respond to rising labour costs and support more sustainable operating models.
This is one of the UK’s core strengths too.
Compared with markets where resident pricing is heavily controlled, the UK’s private pay model remains a significant source of resilience. The lesson from Europe is not that the UK should change course, but that it should better recognise the strategic value of this position.
In an environment where construction costs, staffing pressures and financing costs remain elevated, pricing flexibility is not just commercially helpful. It can be market-defining.
3. New development needs policy support
If there was one constraint mentioned across multiple countries, it was the difficulty of getting new development to stack up.
In Germany, the issue is closely tied to construction cost, regulation and the challenge of funding new schemes. In the UK, the challenge is often planning. In other markets, it may be a question of permits, fragmentation or operational uncertainty.
What is striking is that this is not a local issue. It is a European one.
The UK should take note. Demand for care and later living accommodation is rising, but bringing forward new supply remains too slow and too difficult. The discussion highlighted that without more policy support, faster planning pathways and greater confidence around viability, development will continue to lag behind need.
The lesson from mainland Europe is not that another country has solved this problem. It is that every market is wrestling with it, and the markets that create a clearer route to delivery will have a real competitive advantage.
4. Scale is attractive, but not at any cost
Several pan-European operators described the importance of entering new countries in a disciplined way. Rather than buying the biggest available platform, the preference in some cases has been to acquire smaller, high quality platforms with room to grow.
That is a powerful lesson for the UK market, where investors often face a choice between portfolio scale and asset quality.
European experience suggests that starting with the right platform matters more than starting with the biggest one. A smaller, well-run operating base can offer more control, less downside risk and better long term expansion potential than a large but inconsistent portfolio.
For investors looking at the UK, that is particularly relevant in a market where operational quality and regulatory strength remain central to value.
5. The future is broader than care homes alone
Although residential care and nursing care remained central to the discussion, mainland Europe also offered a broader view of where healthcare real estate may evolve next.
Germany’s discussion highlighted senior living and mixed models. Spain brought attention to the importance of private pay depth and market freedom. Other conversations touched on rehab, specialist care, home care and the role of technology in extending independent living.
For the UK, this is important.
The care home market remains critical, but future growth may increasingly come from a wider continuum of care and accommodation models. Investors who understand how residential care, senior living, home care, rehab and community-based services fit together will be better placed to respond to changing demand.
That does not mean every model works everywhere. But it does mean the UK should keep a close eye on how consumer expectations and care pathways are evolving across Europe.
A European market with local rules
Perhaps the biggest lesson of all is that healthcare real estate in Europe is not one market. It is a collection of local markets, each shaped by its own regulation, funding structure, culture and stage of maturity.
That is exactly why comparative insight matters.
For the UK, the opportunity is not to copy mainland Europe. It is to learn from it. To understand where the UK has structural advantages, where it faces familiar constraints, and where emerging trends elsewhere may signal what comes next.
As Carterwood continues to expand its focus in Spain and deepen its view of Germany, that cross-market perspective becomes more valuable, not less.
Because in healthcare real estate, the investors with the clearest local knowledge often make the best international decisions.
